Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 4, Pages 1801
Publisher
MDPI AG
Online
2021-02-13
DOI
10.3390/ijms22041801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer
- (2020) Alessia Indrieri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of uL3 in the Crosstalk between Nucleolar Stress and Autophagy in Colon Cancer Cells
- (2020) Annalisa Pecoraro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Many ways to resistance: How melanoma cells evade targeted therapies
- (2019) Ines Kozar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- miR‐181a/b downregulation exerts a protective action on mitochondrial disease models
- (2019) Alessia Indrieri et al. EMBO Molecular Medicine
- MicroRNA‐181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP‐1 macrophages stimulated by ox‐LDL
- (2019) Jinyang Song et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A
- (2019) Simona Caporali et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Modulation of biliary cancer chemo‐resistance through microRNA‐mediated rewiring of the expansion of CD133+ cells
- (2019) Pietro Carotenuto et al. HEPATOLOGY
- MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
- (2019) Sagar L. Patil et al. Scientific Reports
- MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma
- (2018) Andrea Lampis et al. GASTROENTEROLOGY
- miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway
- (2018) Jiangang Liu et al. ONCOLOGY REPORTS
- Long Noncoding RNA NEAT1 Promotes Proliferation and Invasion via Targeting miR-181a-5p in Non-Small Cell Lung Cancer
- (2018) ShiDong Li et al. ONCOLOGY RESEARCH
- Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanoma
- (2018) L. F. Araujo et al. Scientific Reports
- Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
- (2017) Maria C Previdi et al. Future Oncology
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications
- (2017) Grant M. Fischer et al. Pigment Cell & Melanoma Research
- MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway
- (2017) Lisa Koetz-Ploch et al. Pigment Cell & Melanoma Research
- BRAFV600inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells
- (2017) Taral R. Lunavat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs in melanoma development and resistance to target therapy
- (2017) Luigi Fattore et al. Oncotarget
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
- (2017) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- Roads to melanoma: Key pathways and emerging players in melanoma progression and oncogenic signaling
- (2016) Jasmina Paluncic et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies
- (2016) Shivshankari Rajkumar et al. BRITISH JOURNAL OF CANCER
- Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma
- (2016) Alexander Roesch et al. EUROPEAN JOURNAL OF CANCER
- Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
- (2016) Gao Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-579-3p controls melanoma progression and resistance to target therapy
- (2016) Luigi Fattore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
- (2016) Xiaoyan Sun et al. Oncotarget
- Synthetic long non-coding RNAs [SINEUPs] rescue defective gene expression in vivo
- (2016) Alessia Indrieri et al. Scientific Reports
- Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells
- (2015) Felix Chang Tay et al. ADVANCED DRUG DELIVERY REVIEWS
- Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction
- (2015) Gatien Moriceau et al. CANCER CELL
- Identification of Cellular Targets of MicroRNA-181a in HepG2 Cells: A New Approach for Functional Analysis of MicroRNAs
- (2015) Jane Yi Lin Tan et al. PLoS One
- Clinical significance of up-regulated miR-181a in prognosis and progression of esophageal cancer
- (2014) Zhengkai Xiang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer
- (2014) S Hasegawa et al. BRITISH JOURNAL OF CANCER
- Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation
- (2014) Daniele De Filippis et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
- (2014) Mao Ouyang et al. PLoS One
- MicroRNA-34a: a potential therapeutic target in human cancer
- (2014) X J Li et al. Cell Death & Disease
- Resistance to BRAF-targeted therapy in melanoma
- (2013) Ryan J. Sullivan et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD
- (2013) Yiran Chen et al. EXPERIMENTAL CELL RESEARCH
- Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity
- (2012) B. Zhou et al. DIABETOLOGIA
- MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non-Small Cell Lung Carcinoma
- (2010) J. Voortman et al. CANCER RESEARCH
- Regulation of mitochondrial biogenesis
- (2010) François R. Jornayvaz et al. Essays in Biochemistry
- Characterization of the Melanoma miRNAome by Deep Sequencing
- (2010) Mitchell S. Stark et al. PLoS One
- MicroRNA sponges: Progress and possibilities
- (2010) M. S. Ebert et al. RNA
- A scaling normalization method for differential expression analysis of RNA-seq data
- (2010) Mark D Robinson et al. GENOME BIOLOGY
- miRNA Expression Profiling in Melanocytes and Melanoma Cell Lines Reveals miRNAs Associated with Formation and Progression of Malignant Melanoma
- (2009) Daniel W. Mueller et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now